Compare · OMCL vs ZEPP
OMCL vs ZEPP
Side-by-side comparison of Omnicell Inc. (OMCL) and Zepp Health Corporation (ZEPP): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OMCL and ZEPP operate in Computer Manufacturing (Technology), so they compete in similar markets.
- OMCL is the larger of the two at $2.09B, about 26.3x ZEPP ($79.2M).
- OMCL has been more active in the news (6 items in the past 4 weeks vs 5 for ZEPP).
- OMCL has more recent analyst coverage (24 ratings vs 0 for ZEPP).
- Company
- Omnicell Inc.
- Zepp Health Corporation
- Price
- $45.80-2.53%
- $5.38+2.77%
- Market cap
- $2.09B
- $79.2M
- 1M return
- +14.67%
- -
- 1Y return
- +70.51%
- -
- Industry
- Computer Manufacturing
- Computer Manufacturing
- Exchange
- NASDAQ
- NYSE
- IPO
- 2001
- News (4w)
- 6
- 5
- Recent ratings
- 24
- 0
Omnicell Inc.
Omnicell, Inc., together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. It also provides point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. In addition, the company provides automated systems to help pharmacies in filling its multimed adherence packaging based on individual patient medication orders; single dose automation solutions to fill and label for incoming prescriptions; semi-automated filling equipment for the long-term care institutional pharmacy; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Zepp Health Corporation
Zepp Health Corporation, a biometric and activity data-driven company, develops, manufactures, and sells smart wearable technological devices in the People's Republic of China. It operates through two segments, Xiaomi Wearable Products, and Self-Branded Products and Others. The company offers smart bands, watches, and scales; and a range of accessories, including bands, watch straps, earphones, sportswear, home gym, treadmill, etc. under the Xiaomi and Amazfit brands. It provides charts and graphs to display analysis of the activity and biometric data collected from users through its Mi Fit and Amazfit mobile apps. Zepp Health Corporation has strategic collaborations with Timex Group to develop smart watches; and AliveCor, Inc. to deliver a medical functionality to wearable devices. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.
Latest OMCL
- CHAIRMAN, CEO Lipps Randall A sold $470,000 worth of shares (10,000 units at $47.00) as part of a pre-agreed trading plan (SEC Form 4)
- Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026
- SEC Form S-8 filed by Omnicell Inc.
- President & COO Njoku Nnamdi was granted 12,309 shares, increasing direct ownership by 8% to 167,094 units (SEC Form 4)
- Omnicell Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Nnamdi Njoku Appointed President of Omnicell
- Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business
- Director Bousa Edward Peter was granted 4,603 shares, increasing direct ownership by 26% to 22,589 units (SEC Form 4)
- Director Scott Bruce E was granted 4,627 shares, increasing direct ownership by 20% to 27,600 units (SEC Form 4)
- Director Seim Robin Gene was granted 4,845 shares, increasing direct ownership by 10% to 52,198 units (SEC Form 4)
Latest ZEPP
- Amazfit Launches Its HYBRID TRAINING Ecosystem in Malaysia, Powered by the New Balance 3 and Balance Ultra
- Chief Technology Officer Fan Meihui converted options into 520,000 units of Class A ordinary shares (SEC Form 4)
- Chief Financial Officer Deng Cheng converted options into 22,875 units of American depositary shares and sold $45,344 worth of American depositary shares (9,836 units at $4.61), increasing direct ownership by 13% to 114,539 units (SEC Form 4) to cover withholding tax
- SEC Form SCHEDULE 13G filed by Zepp Health Corporation
- Amazfit Brings Interactive iOS Notifications to Select Smartwatches in Europe
- Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training
- SEC Form 6-K filed by Zepp Health Corporation
- Zepp Health Corporation Reports First Quarter of 2026 Unaudited Financial Results
- Amazfit Introduces a New Era of Hybrid Training with Balance 3 and Balance Ultra
- Zepp Health Corporation to Report First Quarter 2026 Financial Results on June 8, 2026